These include acute myeloid leukemia through promoting leukemogenesis via FTO-mediated m6A demethylation of core transcripts as ASB2 and RARA mRNAs promoting decreased stability of the target transcripts (Li Z. et al., 2017; Huang et al., 2019; Weng et al., 2019; Zhao et al., 2020). Here, FTO is linked to acute myeloid leukemia.